Significant Ownership of Freebird Partners LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Freebird Partners LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ Curtis Huff - Curtis Huff, Chairman and President
- Manager location
- Houston, TX
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Freebird Partners LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Freebird Partners LP
Significant Ownership of Freebird Partners LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 9.9% | $1,304,421 | +$225,715 | 6,211,530 | +21% | Freebird Partners LP | 31 Mar 2025 |
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 9.9% | $24,082 | -$133,126 | 120,412 | -85% | Freebird Partners LP | 10 Feb 2026 |
Schedules 13D/G Reported by Freebird Partners LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.